Evidence map›Paper›PMID 29674746›Full record

ArticleNature communications2018

Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival.

Megumi Shiota, Masayuki Naya, Takehiro Yamamoto, Takako Hishiki, Takeharu Tani, Hiroyuki Takahashi, Akiko Kubo, Daisuke Koike, Mai Itoh, Mitsuyo Ohmura and 13 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Raman signatures ofFrontiers in microbiology · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hydrogen Sulfide (HBiomolecules · 2024
    Review
  17. Article
  18. Design and Synthesis of SERS Materials for In Vivo Molecular Imaging and Biosensing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 1 country.

Megumi ShiotaFrontier Core-Technology Laboratories, Research & Development Management Headquarters, FUJIFILM Corporation, 577, Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan.ORCID http://orcid.org/0000-0002-8875-8865
Masayuki NayaFrontier Core-Technology Laboratories, Research & Development Management Headquarters, FUJIFILM Corporation, 577, Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan.
Takehiro YamamotoDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0003-4974-9859
Takako HishikiDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0003-3167-6524
Takeharu TaniFrontier Core-Technology Laboratories, Research & Development Management Headquarters, FUJIFILM Corporation, 577, Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan.
Hiroyuki TakahashiAnalysis Technology Center, Research & Development Management Headquarters, FUJIFILM Corporation, 577, Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan.
Akiko KuboDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Daisuke KoikeFunctional Materials R&D Support Department, Research & Development Process Services Division, FUJIFILM Business Expert Corporation, 577, Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan.
Mai ItohDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Mitsuyo OhmuraDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Yasuaki KabeDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Yuki SugiuraDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Nobuyoshi HiraokaPathology Division, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.ORCID http://orcid.org/0000-0003-4215-4385
Takayuki MorikawaDepartment of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
Keiyo TakuboDepartment of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
Kentaro SuinaDivision of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Hideaki NagashimaDivision of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0002-3845-9322
Oltea SampetreanDivision of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0001-5783-1049
Osamu NaganoDivision of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0002-7630-142X
Hideyuki SayaDivision of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID http://orcid.org/0000-0001-6610-1902
Shogo YamazoeFrontier Core-Technology Laboratories, Research & Development Management Headquarters, FUJIFILM Corporation, 577, Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan.
Hiroyuki WatanabeFrontier Core-Technology Laboratories, Research & Development Management Headquarters, FUJIFILM Corporation, 577, Ushijima, Kaisei-machi, Ashigarakami-gun, Kanagawa, 258-8577, Japan.ORCID http://orcid.org/0000-0001-5817-3316
Makoto SuematsuDepartment of Biochemistry, Keio University School of Medicine, Tokyo, 160-8582, Japan. gasbiology@keio.jp.ORCID http://orcid.org/0000-0002-7165-6336
Keio University · JPFujifilm (Japan) · JPNational Center for Global Health and Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gold deposition with diagonal angle towards boehmite-based nanostructure creates random arrays of horse-bean-shaped nanostructures named gold-nanofève (GNF). GNF generates many electromagnetic hotspots as surface-enhanced Raman spectroscopy (SERS) excitation sources, and enables large-area visualization of molecular vibration fingerprints of metabolites in human cancer xenografts in livers of immunodeficient mice with sufficient sensitivity and uniformity. Differential screening of GNF-SERS signals in tumours and those in parenchyma demarcated tumour boundaries in liver tissues. Furthermore, GNF-SERS combined with quantum chemical calculation identified cysteine-derived glutathione and hypotaurine (HT) as tumour-dominant and parenchyma-dominant metabolites, respectively. CD44 knockdown in cancer diminished glutathione, but not HT in tumours. Mechanisms whereby tumours sustained HT under CD44-knockdown conditions include upregulation of PHGDH, PSAT1 and PSPH that drove glycolysis-dependent activation of serine/glycine-cleavage systems to provide one-methyl group for HT synthesis. HT was rapidly converted into taurine in cancer cells, suggesting that HT is a robust anti-oxidant for their survival under glutathione-suppressed conditions.

Indexed as

AnimalsAntioxidantsFemaleGlutathioneGoldHumansLiverMaleMetal NanoparticlesMiceMice, Inbred C57BLMice, SCIDNeoplasmsSpectrum Analysis, RamanTaurineTransaminasesAntioxidantsGlutathioneGoldhypotaurinephosphoserine aminotransferaseTaurineTransaminases

Identifiers

PMID29674746
PMCPMC5908798
OpenAlexW2799842393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.